Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

26
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
26
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

28
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
28
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

47
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Genetic factors contributing to viral myocarditis.

Microbiology and molecular biology reviews : MMBR·2026
Same author

Developing a Personalized Cancer Nanovaccine Using Coxsackievirus-Reprogrammed Cancer Cell Membranes for Enhanced Anti-Tumor Immunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Mitochondrial injury and complement dysregulation are drivers of pathological inflammation in viral myocarditis.

Journal of virology·2025
Same author

Coxsackievirus B3-Induced m<sup>6</sup>A Modification of RNA Enhances Viral Replication via Suppression of YTHDF-Mediated Stress Granule Formation.

Microorganisms·2024
Same author

Crosstalk Between Innate Immunity and Autophagy in Viral Myocarditis Leading to Dilated Cardiomyopathy.

Reviews in medical virology·2024
Same author

Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry.

Viruses·2024

関連する実験動画

Updated: Sep 10, 2025

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.0K

ウイルス性心筋炎における細胞タンパク質品質管理: 分子機構と治療効果

Yasir Mohamud1,2, Jingfei Carly Lin1,2, Sinwoo Wendy Hwang1,2

  • 1Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Microbiology and molecular biology reviews : MMBR
|August 20, 2025
PubMed
まとめ

ウイルス性心筋炎は,タンパク質品質管理 (PQC) システムを乱すことで心筋を損傷します. この相互作用を理解することは ウイルス感染症による心不全の治療法の開発に 鍵となるものです

キーワード:
オートファジー心臓の炎症分子チャペロンタンパク質の品質管理ウビキチン-プロテアソーム経路ウイルス性心筋炎ウイルス病原性

さらに関連する動画

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.7K
Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
10:30

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles

Published on: October 15, 2014

20.7K

関連する実験動画

Last Updated: Sep 10, 2025

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.0K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.7K
Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
10:30

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles

Published on: October 15, 2014

20.7K

科学分野:

  • 心臓病科
  • 分子生物学
  • ウイルス学

背景:

  • ウイルス性心筋炎は,特に若い人の深刻な心疾患です.
  • 心不全につながる可能性があり,その原因をよりよく理解する必要があります.
  • タンパク質品質管理 (PQC) は心臓細胞の健康に不可欠です.

研究 の 目的:

  • PQCシステムとウイルス性心筋炎の複雑な関係を見直す.
  • 現在の知識のギャップを特定する
  • 心臓の機能を保つための治療戦略について話し合う

主な方法:

  • ウイルス性心筋炎とPQCに関する研究の文献レビュー
  • 分子チャペロン,ユビキチン-プロテアソームシステム,およびオートファギーの役割の分析.
  • ホストのPQC経路のウイルスの破壊の検査

主要な成果:

  • ウイルス感染症は 心筋細胞にストレスを与え PQCのメカニズムを圧倒します
  • 損傷したタンパク質と臓器の蓄積は 心臓の損傷を悪化させます
  • ウイルスはPQCを操作して 自身の複製を促進し 心臓の損傷を悪化させます

結論:

  • PQCの破壊は,ウイルス性心筋炎の病原性において中心的なものです.
  • PQC経路をターゲットにすると 新しい治療法が生まれます
  • PQCの役割を完全に解明し,効果的な治療法を開発するには,さらなる研究が必要です.